Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.07 USD | +0.04% | -0.39% | -8.84% |
May. 02 | Enovis Q1 Shares Fall Following Q1 Results | MT |
May. 02 | Transcript : Enovis Corporation, Q1 2024 Earnings Call, May 02, 2024 |
Chart calendar Enovis Corporation
Upcoming events on Enovis Corporation
Past events on Enovis Corporation
2024-05-02 08:00 am | Q1 2024 Earnings Call |
2024-05-02 06:00 am | Q1 2024 Earnings Release |
2024-04-09 03:45 pm | Needham Healthcare Conference |
2024-02-22 08:30 am | Q4 2023 Earnings Call |
2024-02-22 06:00 am | Q4 2023 Earnings Release |
2024-02-14 | American Academy of Orthopaedic Surgeons Conference |
2024-02-12 05:30 pm | Canaccord Genuity Musculoskeletal Conference |
2024-01-31 | American College of Foot And Ankle Surgeons Meeting |
2024-01-08 12:45 pm | JPMorgan Healthcare Conference |
2023-11-29 10:00 am | Evercore ISI HealthCONx Conference |
2023-11-07 08:00 am | Q3 2023 Earnings Call |
2023-11-07 06:00 am | Q3 2023 Earnings Release |
2023-11-01 | American Association of Hip and Knee Surgeons Meeting |
2023-09-25 08:30 am | Acquisition of LimaCorporate S.p.A. by Enovis Corp Call |
2023-09-19 | American Orthopedic Foot and Ankle Society Meeting |
2023-09-12 08:30 am | Baird Global Healthcare Conference |
2023-08-09 11:30 am | Canaccord Genuity Growth Conference |
2023-08-03 08:30 am | Q2 2023 Earnings Call |
2023-08-03 06:00 am | Q2 2023 Earnings Release |
2023-07-12 | American Orthopedic Society of Sports Medicine Meeting |
Past dividends on Enovis Corporation
2022-04-04 | 0 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3 327 3 366 -1.14% | 3 071 3 071 0.01% | 3 854 3 840 0.36% | 1 563 1 570 -0.45% | 1 707 1 698 0.57% | 2 126 |
EBITDA Million USD | Released Forecast Spread | 505 582 -13.18% | 463 462 0.19% | 623 610 2.17% | 236 236 0.04% | 269 267 0.69% | 375 |
EBIT Million USD | Released Forecast Spread | 269 309 -13.1% | 217 213 1.8% | 360 327 10.29% | 159 160 -0.65% | 186 158 17.45% | 260 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 50,5 52,4 -3.72% | 58,0 81,8 -29.05% | 165 193 -14.09% | -2,07 5,35 -138.67% | -67,1 -81,4 17.53% | -118 |
Net income Million USD | Released Forecast Spread | -528 -455 -15.95% | 42,6 51,2 -16.71% | 71,7 142 -49.65% | -13,3 49,9 -126.66% | -33,3 -42,0 20.85% | -29,5 |
EPS USD | Released Forecast Spread | -11,7 -9,89 -18.06% | 0,93 1,17 -20.38% | 1,38 2,78 -50.43% | -0,25 0,91 -127.47% | -0,61 -0,84 26.95% | -0,46 |
Announcement Date | 21/02/20 | 18/02/21 | 22/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 376 367 2.2% | 395 400 -1.28% | 384 382 0.47% | 409 416 -1.7% | 406 390 4.15% | 429 419 2.32% | 418 414 0.77% | 455 445 2.16% | 516 506 2.11% | 530 | 515 | 566 | 554 | 574 |
EBITDA Million USD | Released Forecast Spread | 47,7 44,3 7.8% | 56,2 56,0 0.31% | 57,2 54,8 4.46% | 74,9 75,1 -0.23% | 56,4 51,6 9.3% | 65,7 62,4 5.37% | 65,4 63,8 2.44% | 81,7 79,8 2.42% | 83,2 80,2 3.68% | 90,1 | 91,6 | 110 | 88,7 | 101 |
EBIT Million USD | Released Forecast Spread | 29,1 27,8 4.86% | 36,7 38,5 -4.61% | 39,1 35,9 8.69% | 54,3 56,1 -3.21% | 36,4 31,2 16.52% | 44,9 41,1 9.14% | 43,9 42,5 3.34% | 60,3 50,5 19.49% | 56,0 52,8 6.07% | 61,8 | 61,2 | 80,7 | 59,5 | 70,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -46,2 -21,0 -120% | 116 11,8 886.78% | -78,3 13,1 -696.03% | -2,54 4,90 -151.84% | -30,0 -17,8 -68.78% | -19,3 -2,58 -650.41% | -25,5 -13,2 -93.69% | 7,66 7,77 -1.49% | -79,2 -9,99 -693.42% | -21,5 | -17,8 | 0,93 | -23,2 | -10,2 |
Net income Million USD | Released Forecast Spread | -39,4 -12,1 -225.62% | 76,9 13,2 483.71% | -66,6 9,80 -779.71% | -38,6 14,9 -358.5% | -23,4 -14,2 -64.44% | -10,00 2,20 -554.32% | -2,88 -3,70 22.16% | 2,96 6,18 -52.07% | -72,0 -2,79 -2483.91% | 1,66 | 3,14 | 17,7 | -18,6 | -8,30 |
EPS USD | Released Forecast Spread | -0,72 -0,22 -229.21% | 1,41 0,27 428.74% | -1,23 0,18 -796.21% | -0,71 0,27 -359.76% | -0,43 -0,26 -65.38% | -0,18 0,04 -573.68% | -0,05 -0,07 25% | 0,05 0,15 -67.21% | -1,32 0,11 -1322.22% | 0,08 | 0,10 | 0,37 | 0,04 | 0,23 |
Announcement Date | 10/05/22 | 04/08/22 | 02/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 07/11/23 | 22/02/24 | 02/05/24 | - | - | - | - | - |
Past sector events for Enovis Corporation
2024-05-08 | DENTIUM CO., LTD: Q1 2024 Earnings Release |
2024-05-07 04:02 pm | INSPIRE MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
2024-05-06 04:05 pm | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
2024-05-02 06:00 am | ENOVIS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 04:05 pm | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 02:00 am | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
2024-04-30 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
2024-04-30 04:05 pm | STRYKER CORPORATION: Q1 2024 Earnings Release |
2024-04-30 04:01 pm | AXONICS, INC.: Q1 2024 Earnings Release |
2024-04-29 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENOV Stock
- Calendar Enovis Corporation